HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr |
What is the latest Revenue of HIKAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹2,023 Cr |
| Mar2023 | ₹1,943 Cr |
| Mar2022 | ₹1,720 Cr |
| Mar2021 | ₹1,507 Cr |
How is Revenue of HIKAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -11.79 | |
| Mar2024 | ₹2,023 Cr | 4.13 | |
| Mar2023 | ₹1,943 Cr | 12.92 | |
| Mar2022 | ₹1,720 Cr | 14.14 | |
| Mar2021 | ₹1,507 Cr | - | |
Compare Revenue of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,962.9 Cr | 0.2% | -6.9% | -30.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,804.0 Cr | 0.3% | 4.1% | -9.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,764.0 Cr | -1.7% | 8.5% | 13.2% | Stock Analytics | |
| CIPLA | ₹126,807.0 Cr | -3.4% | 3% | 4.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,099.0 Cr | 0.7% | -0.5% | 7.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,707.0 Cr | 0.2% | -1.1% | -3.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 0.2% |
-6.9% |
-30.4% |
| SENSEX | 0.3% |
3.6% |
5.5% |
You may also like the below Video Courses